Enterprise Plenary Session III

Talks

Oral Session II B
Margarida Carvalho
Done
Hot Topics I: Proteins vs. Nucleic Acids as Diagnostic tool
Joana Guerreiro (PhD) and Professor Rúben Fernandes (PhD)/Cláudia Pereira (PhD)
Done
Plenary Session IV
Professor Jens Pahnke
Done
Coffee Break

Done
Oral Session IV A
Nádia Oliveira
Done
Oral Session I A
Cristiana Mateus
Done
Enterprise Plenary Session I
Josué Carvalho (Ph.D.)
Done
Flash Session III (A)
Inês Serrenho
Done
Flash Session III (B)
Andreia Magalhães
Done
Enterprise Plenary Session II
Carlos Neto (PharmD)
Done

15/02/2023, 09:40 - 15/02/2023, 10:40 (UTC) (1 hour)

Sofia Venceslau (Ph.D.) Project Manager at GenIbet Biopharmaceuticals sofia.venceslau@genibet.com

GenIbet Biopharmaceuticals is a company whose mission is to manufacture safe and reliable breakthrough products to support worldwide customers on building the therapies of the future. With a team of more than 50 highly qualified professionals, GenIbet supports its customers on the development and manufacturing of unique novel modalities covering a wide range of technologies.
Sofia Venceslau obtained her Ph.D. degree from the NOVA University of Lisbon, Institute of Chemical and Biological Technology (Oeiras, Portugal) in 2011 and is currently a Project Manager in GenIbet Biopharmaceuticals and will be the third confirmed enterprise speaker for the HSR Congress 2023 on February 15th, 2023.